about
Risk of breast and prostate cancer is not associated with increased homozygosity in outbred populationsLoci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemiaInherited variation in immune genes and pathways and glioblastoma riskThe CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myelomaGenetic advances in glioma: susceptibility genes and networksCommon variation at 10p12.31 near MLLT10 influences meningioma risk.Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survivalIdentification of susceptibility loci for colorectal cancer in a genome-wide meta-analysisVariation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia riskGenome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium.Genetic risk profiles identify different molecular etiologies for glioma.Rationale for an international consortium to study inherited genetic susceptibility to childhood acute lymphoblastic leukemia.A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancerRecurrent Coding Sequence Variation Explains Only A Small Fraction of the Genetic Architecture of Colorectal CancerMeta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.Insight in glioma susceptibility through an analysis of 6p22.3, 12p13.33-12.1, 17q22-23.2 and 18q23 SNP genotypes in familial and non-familial glioma.Health characteristics and consultation patterns of people with intellectual disability: a cross-sectional database study in English general practice.Deciphering the 8q24.21 association for glioma.Deciphering the genetic architecture of low-penetrance susceptibility to colorectal cancer.Do health checks for adults with intellectual disability reduce emergency hospital admissions? Evaluation of a natural experiment.New insights into susceptibility to glioma.Genome-wide association studies for detecting cancer susceptibility.Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.Interaction between 5 genetic variants and allergy in glioma risk.Erratum: A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer.Learning disability registers in primary care.Inherited genetic susceptibility to monoclonal gammopathy of unknown significance.Inference from genome-wide association studies using a novel Markov model.Allergy and glioma risk: test of association by genotype.Mortality Among Adults With Intellectual Disability in England: Comparisons With the General Population.Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood.Role of 657del5 NBN mutation and 7p12.2 (IKZF1), 9p21 (CDKN2A), 10q21.2 (ARID5B) and 14q11.2 (CEBPE) variation and risk of childhood ALL in the Polish population.MHC variation and risk of childhood B-cell precursor acute lymphoblastic leukemiaGenome-wide homozygosity signatures and childhood acute lymphoblastic leukemia risk
P50
Q24597823-134BDFCF-6DA9-47F0-B913-FE97A5A91A73Q28255265-D8772336-D7E4-4948-9431-4AE8D97B33BEQ28383820-46C71CE2-F72A-4B20-9EAD-68C1F45767DDQ28391289-F2343CF4-B553-411F-A835-FD5E670A13A4Q28396146-D3DA13E8-4380-407B-9347-8C108DE5876FQ28943376-4CCE88B2-904A-4EA6-B031-C49A1549DDE4Q33897620-FFA56E64-E5AA-439A-B715-FF19A983976AQ34048230-2E0CAF8F-32B1-4C47-A299-D9E2FC13DAD0Q34114297-01B0C50D-9509-43A6-99AB-7CE9006F49C2Q34228664-1ED80F3A-ED62-499C-BBFF-A90993C8A792Q34341061-5805F57A-7330-45D8-AAB1-E40B51C81AFBQ35082533-E2A0A9A1-D0C8-46EC-8B8A-6D08FB997C28Q35626744-8B2541E8-442F-4CA1-9E02-60517AE7C6C8Q36265886-ACB4619A-BD3F-4590-BAE3-080D20470B70Q36333368-AFC3AA19-0E01-43C3-ACCA-9661D76BA4CDQ36706719-1B37E9F8-BB0C-4CA4-9033-0B7F1FAC18FEQ36734307-C78D0C4F-20D7-4AA9-88CE-D8D10C652104Q36839027-E73EAFDC-5C25-4892-AAB0-B437245BE1DEQ37332239-ECC073CF-68B6-4043-9E0B-66451ED98EFFQ37599882-C3FEC73C-06F4-4A49-82A3-500429E48276Q37704873-BFCE29E2-378E-4A12-82DB-34F5C00FEA62Q37830176-99297395-C590-44BB-89AD-877EE763C496Q39006292-D529EA01-3DA4-4184-A9F3-A0D35EA4A144Q40358881-8A96399D-D577-4303-A267-ABA5E8639C75Q42412214-8A1FA67B-021B-4075-A8EF-1517C9CFB4E2Q42570496-CF650800-FDC7-4D8B-A788-34D24C0A737FQ43496882-D5A028F9-9FBB-4EA7-94D0-2A50FE83915DQ44971105-9142E5A5-B006-4D26-8066-FB8CD8CD0C53Q48185601-B437D48A-E371-466D-9951-806E2BB73380Q53079946-18FDC6D6-53F9-4BA1-97DC-16A7BF27E076Q53350910-CE82EB52-4D82-483B-B166-34F0D4F22BABQ54350836-C50B17EC-7C6C-4DCA-8303-BC2529203BF1Q57214370-2ECB1DC6-DDED-4E16-863C-CF97E77D431CQ57214846-42ECAA5C-EE3F-47B7-AE33-65FEB340BB25
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Fay J Hosking
@ast
Fay J Hosking
@en
Fay J Hosking
@es
Fay J Hosking
@nl
Fay J Hosking
@sl
type
label
Fay J Hosking
@ast
Fay J Hosking
@en
Fay J Hosking
@es
Fay J Hosking
@nl
Fay J Hosking
@sl
altLabel
Fay Hosking
@en
prefLabel
Fay J Hosking
@ast
Fay J Hosking
@en
Fay J Hosking
@es
Fay J Hosking
@nl
Fay J Hosking
@sl
P106
P31
P496
0000-0002-1101-039X